New features in the treatment of androgen-independent prostate cancer.
D000728:Androgens / Q000502:physiology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000628:therapy*; D020794:Receptor Protein-Tyrosine Kinases / Q000502:physiology; D011944:Receptors, Androgen / Q000502:physiology
D000728:Androgens; D000970:Antineoplastic Agents; D011944:Receptors, Androgen; D020794:Receptor Protein-Tyrosine Kinases